Andrew H Galligan's Net Worth

$15.9 Million

Estimate Recalculated Jul 2, 2024 03:30PM EST

Who is Andrew H Galligan?

Andrew H Galligan has an estimated net worth of $15.9 Million. This is based on reported shares across multiple companies, which include OOMA INC, NEVRO CORP, Diadexus, Inc., and diaDexus, Inc. (pre-merger).

SEC CIK

Andrew H Galligan's CIK is 0001417976

Past Insider Trading and Trends

2016 was Andrew H Galligan's most active year for acquiring shares with 11 total transactions. Andrew H Galligan's most active month to acquire stocks was the month of October. 2016 was Andrew H Galligan's most active year for disposing of shares, totalling 23 transactions. Andrew H Galligan's most active month to dispose stocks was the month of October. 2020 saw Andrew H Galligan paying a total of $1,325,015.00 for 38,951 shares, this is the most they've acquired in one year. In 2020 Andrew H Galligan cashed out on 51,311 shares for a total of $2,742,781.78, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OOMA INC (OOMA) Snapshot price: $10.23

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.78%
19.76K
—
—
221.83K
Jun 6
Form 4
+6.19%
11.78K
—
—
202.07K
Jun 1
Form 4
+6.35%
11.36K
—
—
190.29K
Jun 1
Form 4
+4.37%
7.5K
—
—
178.93K
Jun 2
Form 4
+6.49%
10.45K
—
—
171.44K
Jun 3
Form 4
-13.44%
-25.00K
$10.50
-$262,400.00
160.98K
Sep 23
Form 4
-11.85%
-25.00K
$12.31
-$307,655.00
185.98K
Sep 10
Form 4
+174.42%
134.1K
$0.90
$120,690.00
210.98K
Jul 8
Form 4
+14.28%
9.61K
—
—
76.88K
Jun 10
Form 4
+19.36%
10.91K
—
—
67.28K
Jun 6
Form 4
+29.40%
12.8K
—
—
56.37K
Jun 20
Form 4
+47.36%
14K
—
—
43.56K
Jun 16
Form 4
+48.21%
9.62K
—
—
29.56K
Jul 16
Form 3
—
0
—
—
0
No matching records found

NEVRO CORP (NVRO) Snapshot price: $17.1139

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.76%
-2.31K
$121.53
-$280,855.83
59.18K
Jun 4
Form 4
+14.96%
8K
$3.60
$28,800.00
61.49K
Feb 28
Form 4
—
0
$91.67
-$1,007,776.81
53.49K
Scheduled
Jan 8
Form 4
—
0
$91.62
-$157,934.14
53.49K
Scheduled
Jan 6
Form 4
—
0
$86.81
-$565,953.60
53.49K
Scheduled
Nov 25
Form 4
—
0
$75.50
-$1,044,574.93
53.49K
Scheduled
Nov 11
Form 4
-3.10%
-1.71K
$86.63
-$148,397.19
53.49K
Nov 1
Form 4
+4.74%
2.5K
$3.60
$9,000.00
55.2K
Jul 16
Form 4
+19.40%
8.56K
—
—
52.7K
May 28
Form 4
+33.21%
11K
$1.44
$15,845.76
44.14K
Jan 4
Form 4
-6.90%
-2.46K
$49.40
-$121,375.80
33.13K
Nov 1
Form 4
+26.25%
7.4K
$1.44
$10,656.00
35.59K
Jul 18
Form 4
—
0
$47.07
-$406,959.00
28.19K
Scheduled
May 14
Form 4
—
0
$49.05
-$434,711.27
28.19K
Scheduled
Mar 1
Form 4
+85.57%
13K
$46.56
-$399,739.90
28.19K
Scheduled
Nov 14
Form 4
+35.74%
4K
$1.44
$5,760.00
15.19K
Nov 9
Form 4
-5.42%
-641.00
$88.99
-$57,042.59
11.19K
Nov 1
Form 4
—
0
$43.17
-$548,054.80
11.83K
Scheduled
Aug 14
Form 4
—
0
$39.45
-$537,734.30
11.83K
Scheduled
May 15
Form 4
+73.17%
5K
$1.44
$7,200.00
11.83K
May 9
Form 4
-81.45%
-30.00K
$94.46
-$2,833,828.57
6.83K
Scheduled
Apr 3
Form 4
—
0
$49.30
-$685,530.81
36.83K
Scheduled
Mar 1
Form 4
+22.78%
6.83K
—
—
36.83K
Nov 16
Form 4
—
0
$49.27
-$564,489.77
30K
Scheduled
Nov 15
Form 4
—
0
$55.50
-$633,114.80
30K
Scheduled
Aug 15
Form 4
—
0
$33.11
-$633,447.00
30K
Scheduled
May 16
Form 4
+566.67%
25.5K
$1.44
$36,720.00
30K
Mar 17
Form 4
∞
4.5K
$28.65
-$537,791.42
4.5K
Scheduled
Dec 29 - Mar 1
Form 4
—
0
—
—
0
Dec 1
Form 4
—
0
$28.54
-$909,996.46
0
Scheduled
Nov 17
Form 4
—
0
—
—
0
Nov 5
Form 3
—
0
—
—
0
No matching records found

Diadexus, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 29
Form 4
∞
6.5K
—
—
6.5K
Aug 6
Form 4
—
0
—
—
0
Sep 20
Form 4
—
0
—
—
0
Aug 10
Form 4
—
0
—
—
0
Nov 4
Form 3
—
0
—
—
0
No matching records found

diaDexus, Inc. (pre-merger) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found